...
首页> 外文期刊>Journal of vascular surgery >Safety and efficacy of carotid angioplasty and stenting for radiation-associated carotid artery stenosis.
【24h】

Safety and efficacy of carotid angioplasty and stenting for radiation-associated carotid artery stenosis.

机译:放射相关颈动脉狭窄的颈动脉血管成形术和支架置入的安全性和有效性。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Prior neck irradiation may induce atherosclerosis in the carotid artery and is considered an indication for carotid angioplasty and stenting (CAS). This study sought to evaluate the effect of neck radiation therapy (XRT) on the rate of restenosis and embolic potential in patients undergoing CAS. METHODS: Two hundred ten CAS procedures were performed on 193 patients (XRT [N = 28], non-XRT [N = 182]). Mean follow-up was 347 +/- 339 days (median, 305 days; range, 16-1354 days). Duplex velocity criteria for restenosis after CAS were: >50% restenosis (peak systolic velocity [PSV] > 125 cm/sec, end diastolic velocity [EDV] 40-99 cm/sec, and internal carotid artery to common carotid artery systolic ratio [ICA/CCA] > 2.0); >70% restenosis (PSV>230 cm/sec, EDV>100 cm/sec, and ICA/CCA ratio >4.0). Restenosis >70% was confirmed by digital subtraction angiography. Additional endpoints included groin hematoma, groin pseudoaneurysm, myocardial infarction, stroke, mortality, and the combined myocardial infarction/stroke/mortality rate. Captured particulate data was obtained from microporous filters used during CAS. Nineteen XRT and 128 non-XRT consecutive filters were analyzed. Photomicroscopy was performed along three axes for each filter, and the quantity and size of the captured particles were analyzed using video image analysis software. RESULTS: There were more men (XRT: 85.7% vs. non-XRT: 52.8%, P < .001) and prior surgical neck dissections in the XRT patients (XRT: 82.1% vs. non-XRT: 4.7%, P < .001). Pre-procedural stenosis did not differ significantly betweeen the two groups (XRT: 86.5% +/- 8.9% [range, 70%-99%] vs. non-XRT: 85.5% +/- 8.7% [range 70%-99%], P = NS). Perioperative outcomes, including the composite 30 day stroke/myocardial infarction/mortality rate did not differ significantly between the two groups (XRT: 0% vs. non-XRT: 3.2%, P = NS). Twelve-month freedom from restenosis rates did not differ significantly at the 50% threshold (XRT: 95.5% vs. non-XRT: 90.3%, P = NS) or at the 70% threshold (XRT: 95.5% vs. non-XRT: 96.5%, P = NS). Target lesion revascularization did not differ significantly (XRT: 0% vs. non-XRT: 0.5%, P = NS). Photomicroscopy demonstrated a trend towards increased particle number and size in the XRT filters, however the results did not achieve statistical significance: particle number (XRT: 9.8 +/- 8.4 vs. non-XRT: 9.6 +/- 11.7, P = NS), %patients with particle size >1000 microm (XRT: 47.4% vs. non-XRT: 30.5%, P = NS). CONCLUSIONS: This study suggests that the durability of CAS and the characteristics of captured embolic particles are not altered by a history of neck XRT. This supports the safety and efficacy of CAS for the treatment of patients with a history of neck XRT. Prior neck XRT may predispose the patient to the de novo development of stenoses at locations that were not previously treated.
机译:简介:先前的颈部照射可能会诱发颈动脉粥样硬化,被认为是颈动脉血管成形术和支架置入术(CAS)的指征。这项研究试图评估接受CAS的患者颈部放射治疗(XRT)对再狭窄率和栓塞潜能的影响。方法:对193例患者进行了210次CAS手术(XRT [N = 28],非XRT [N = 182])。平均随访时间为347 +/- 339天(中位数为305天;范围为16-1354天)。 CAS后再狭窄的双重速度标准为:> 50%再狭窄(峰值收缩速度[PSV]> 125 cm / sec,舒张末期速度[EDV] 40-99 cm / sec,以及颈内动脉与颈总动脉收缩率[ ICA / CCA]> 2.0);再狭窄> 70%(PSV> 230 cm / sec,EDV> 100 cm / sec,ICA / CCA比> 4.0)。数字减影血管造影证实再狭窄> 70%。其他终点包括腹股沟血肿,腹股沟假性动脉瘤,心肌梗塞,中风,死亡率以及合并的心肌梗塞/中风/死亡率。捕获的颗粒数据是从CAS期间使用的微孔过滤器获得的。分析了19个XRT和128个非XRT连续滤波器。沿每个滤光片的三个轴进行光学显微镜检查,并使用视频图像分析软件分析捕获颗粒的数量和大小。结果:XRT患者中有更多男性(XRT:85.7%,非XRT:52.8%,P <.001)和先前的手术性颈淋巴结清扫术(XRT:82.1%vs.非XRT:4.7%,P < .001)。两组之间的术前狭窄无显着差异(XRT:86.5%+/- 8.9%[范围,70%-99%]与非XRT:85.5%+/- 8.7%[范围70%-99 %],P = NS)。两组的围手术期结局(包括30天卒中/心肌梗塞/死亡率的复合率)无显着差异(XRT:0%;非XRT:3.2%,P = NS)。在50%阈值(XRT:95.5%相对非XRT:90.3%,P = NS)或70%阈值(XRT:95.5%与非XRT相比)的十二个月无再狭窄率没有显着差异:96.5%,P = NS)。靶病变血运重建没有显着差异(XRT:0%与非XRT:0.5%,P = NS)。光学显微镜显示了XRT过滤器中的颗粒数量和尺寸增加的趋势,但是结果并未达到统计学显着性:颗粒数量(XRT:9.8 +/- 8.4与非XRT:9.6 +/- 11.7,P = NS) ,%粒度大于1000微米的患者(XRT:47.4%与非XRT:30.5%,P = NS)。结论:这项研究表明CAS的耐久性和捕获的栓塞颗粒的特征不会因颈部XRT的病史而改变。这支持了CAS治疗具有颈部XRT病史的患者的安全性和有效性。先前的颈部XRT可能会使患者在以前未进行过治疗的位置处重新开始狭窄。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号